#FGDebate: Should we focus on detecting patients at risk of liver disease in the community?

Affiliations

¹ Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
² Leeds Liver Unit, St James's University Hospital, Leeds, UK.
³ The Sheila Sherlock Liver Centre, Royal Free Hospital, London, UK.
⁴ Division of Clinical and Molecular Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
⁵ Leeds Institute for Medical Research, University of Leeds & Leeds Liver Unit, St James's University Hospital, Leeds, UK.

Editorial

Kushala Wm Abeysekera et al. Frontline Gastroenterol. 2022.

. 2022 Dec 1;14(4):343-345.

doi: 10.1136/flgastro-2022-102330. eCollection 2023.

¹ Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
² Leeds Liver Unit, St James's University Hospital, Leeds, UK.
³ The Sheila Sherlock Liver Centre, Royal Free Hospital, London, UK.
⁴ Division of Clinical and Molecular Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
⁵ Leeds Institute for Medical Research, University of Leeds & Leeds Liver Unit, St James's University Hospital, Leeds, UK.

No abstract available

Keywords: CHRONIC LIVER DISEASE; SCREENING.

Conflict of interest statement

Competing interests: ODT is a Trainee Associate Editor at Frontline Gastroenterology. All other declare no conflicts in interest.

1. Macpherson I, Abeysekera KWM, Harris R, et al. Identification of liver disease: why and how. Frontline Gastroenterol 2022;13:367–73. 10.1136/flgastro-2021-101833 - DOI - PMC - PubMed
1. British Liver Trust . The alarming impact of liver disease in the UK: facts and statistics. British Liver Trust, 2019.
1. Sheiybani G. O21 chronic liver disease emergency admissions are for patients with preventable, established liver disease. Gut 2022;71. 10.1136/gutjnl-2022-BSG.21 - DOI
1. Williams R, Aspinall R, Bellis M, et al. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. The Lancet 2014;384:1953–97. 10.1016/S0140-6736(14)61838-9 - DOI - PubMed
1. Subhani M, Knight H, Ryder S, et al. Does advice based on biomarkers of liver injury or non-invasive tests of liver fibrosis impact high-risk drinking behaviour: a systematic review with meta-analysis. Alcohol Alcohol 2021;56:185–200. 10.1093/alcalc/agaa143 - DOI - PubMed